- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 4th, 2005
When companies partner with one another, it is with the expectation that each has a role to play. Each is expected to perform its part conscientiously and expeditiously. When one partner doesn't hold up its end of the bargain, it results in delays, lost opportunities and, most importantly for companies, lost revenues.
Such is the case with the just-severed deal between pharmaceutical Biovail and nanotech developer Flamel.
|Related News Press|
Nanometrics Announces Upcoming Investor Events May 10th, 2016
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016